By MEDELPHARM
MEDELPHARM under new leadership
Beynost, (Lyon), France: Jean-Yves Balfin has taken over as new General Manager of research-based manufacturer and powder compaction specialist MEDELPHARM.
Mr. Balfin, previously MEDELPHARM Director of Finance & Administration, succeeds Bruno Villa, who is stepping down after more than 20 years in the leadership position, along with his fellow MEDELPHARM co-founder Ingrid Coyle, Director of Communications.
KORSCH connections
The change of leadership at MEDELPHARM was announced by parent company KORSCH AG, the world leader in high performance tablet presses .
Jean-Yves Balfin is highly experienced in KORSCH tableting technology having spent more than 25 years in Sales and Product Management for the KORSCH agent FARPI-FRANCE and then as KORSCH Area Sales Manager in Berlin and later Product Manager up to January 2024, when he joined MEDELPHARM.
This experience is significant in a business context in which MEDELPHARM STYL’One compaction simulation technology is becoming a key component in end-to-end offers from KORSCH that extend from R&D, through scale-up, to high-speed tablet production.
About MEDELPHARM
Headquartered near Lyon, MEDELPHARM is a high-precision engineering company manufacturing R&D tablet presses and providing innovative solutions for powder analysis and formulation.
Since 1985, MEDELPHARM has been the specialist in tableting instruments ‘Made by people for people’, with high-speed and precision but at the same time very easy-to-use.
Since the end of 2022, it has been a member of the international KORSCH Group, enhancing its worldwide reach.
For more information, visit: www.medelpharm.com